Ovarian germ cell tumor
MONDO:0011366A neoplasm that arises from the ovary and originates from germ cells. Representative examples include teratoma, embryonal carcinoma, yolk sac tumor, and dysgerminoma.
Also known as: germ cell neoplasm of ovary, germ cell neoplasm of the ovary, germ cell tumor of ovary, germ cell tumor of the ovary, germ cell tumour of ovary, germ cell tumour of the ovary, ovarian germ cell neoplasm, ovarian germ cell tumor
1454 clinical trials for this condition and its sub-types, 9 tagged with Ovarian germ cell tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Ovarian germ cell tumor
-
Malignant germ cell tumor of ovary 2 trials · 4 incl. sub-types
4 sub-types
- Ovarian primitive germ cell tumor 0 trials · 2 incl. sub-types Sub-types →
- Choriocarcinoma of ovary 1 trial Sub-types →
- Malignant dysgerminomatous germ cell tumor of ovary 0 trials
- Primary non-gestational choriocarcinoma of ovary 0 trials
-
Ovarian teratoma 0 trials · 3 incl. sub-types
3 sub-types
- Childhood teratoma of the ovary 1 trial · 2 incl. sub-types Sub-types →
- Ovarian biphasic or triphasic teratoma 0 trials · 2 incl. sub-types Sub-types →
- Ovarian monodermal teratoma 0 trials Sub-types →
-
Pediatric ovarian germ cell tumor 0 trials · 2 incl. sub-types
5 sub-types
- Childhood teratoma of the ovary 1 trial · 2 incl. sub-types Sub-types →
- Childhood choriocarcinoma of the ovary 0 trials
- Childhood ovarian embryonal carcinoma 0 trials
- Childhood ovarian yolk sac tumor 0 trials
- Pediatric ovarian dysgerminoma 0 trials
-
Ovarian cystic teratoma 0 trials
1 sub-type
- Dermoid cyst of ovary 0 trials
Most studied deeper sub-types
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for incurable germ cell tumors? cabozantinib trial underway
Disease control OngoingThis phase II trial is testing the drug cabozantinib in 50 patients with germ cell tumors that have not responded to standard chemotherapy. The goal is to see if the drug can stop or slow tumor growth. Patients take cabozantinib daily until the disease worsens or side effects bec…
Phase 2 • Sponsor: Jennifer King • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Massive ovarian cancer screening trial tests whether early detection cuts deaths
Knowledge-focused OngoingThis study enrolled over 78,000 women to see if regular screening with ultrasound and blood tests can lower the number of deaths from ovarian cancer. Participants were randomly assigned to either receive screening or usual care. The goal is to find out if catching the cancer earl…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC